swainsonine has been researched along with Uterine Cervical Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernadinelli, I; Boccardo, E; Cipelli, M; de Assis, JB; Hebster, S; Laginha, F; Lepique, AP; Manzine, C; Rabelo-Santos, SH; RodrÃguez RodrÃguez, G; Silveira, CRF; Termini, L; Villa, LL; Zeferino, LC | 1 |
1 other study(ies) available for swainsonine and Uterine Cervical Neoplasms
Article | Year |
---|---|
Swainsonine, an alpha-mannosidase inhibitor, may worsen cervical cancer progression through the increase in myeloid derived suppressor cells population.
Topics: alpha-Mannosidase; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Disease Progression; Female; Humans; Interleukin-10; Interleukin-6; Leukocytes; Macrophages; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Swainsonine; Tumor Microenvironment; Up-Regulation; Uterine Cervical Neoplasms | 2019 |